INO: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, INO has $69,385,656 in assets. $77,105,633 in debts. $36,567,420 in cash and cash equivalents.

Unit: Dollar

Balance Sheets	2025-09-30	2025-06-30
Cash and cash equivalents	36,567,420	24,351,377
Short-term investments	14,235,770	23,198,083
Accounts receivable from affiliated entity	978,590	840,312
Prepaid expenses and other current assets	3,398,534	4,307,377
Total current assets	55,180,314	52,697,149
Fixed assets, net	2,740,356	3,089,293
Investments in affiliated entity	2,495,730	3,085,348
Operating lease right-of-use assets	6,956,780	7,356,238
Other assets	2,012,476	2,012,476
Total assets	69,385,656	68,240,504

Accounts payable and accrued expenses-Nonrelated Party	15,323,520	15,750,691
Accounts payable and accrued expenses-Related Party	379,721	369,370
Accrued clinical trial expenses	955,970	1,510,984
Common stock warrant liabilities	50,384,043	11,420,326
Operating lease liability	2,738,490	2,656,239
Grant funding liability from affiliated entity	42,152	-
Total current liabilities	69,823,896	31,707,610
Operating lease liability, net of current portion	7,281,737	8,001,989
Total liabilities	77,105,633	39,709,599
Preferred stock	0	0
Common stock	53,572	36,719
Additional paid-in capital	1,811,803,850	1,802,589,299
Accumulated deficit	-1,818,930,043	-1,773,433,371
Accumulated other comprehensive loss	-647,356	-661,742
Total inovio pharmaceuticals, inc. stockholders equity	-7,719,977	28,530,905
Total liabilities and stockholders equity	69,385,656	68,240,504